Lansoprazole
NDC 51079-121, lansoprazole, capsule, delayed release pellets, from Mylan Institutional Inc..
- Product NDC
- 51079-121
- Status
- Listed
- Labeler
- Mylan Institutional Inc.
- Dosage form
- CAPSULE, DELAYED RELEASE PELLETS
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090763
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51079-121 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LANSOPRAZOLE30 mg/1
Pharmacologic classes
Inhibition Gastric Acid Secretion [PE]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51079-121-08 | 51079012108 | 80 BLISTER PACK in 1 CARTON (51079-121-08) / 1 CAPSULE, DELAYED RELEASE PELLETS in 1 BLISTER PACK (51079-121-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/eea82d0b-6600-4693-a2b8-596a55458f61NADAC price for package 51079012108
GET /v1/drugs/nadac/51079012108
Use it
Look up 51079-121 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51079-121 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51079-121. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.